Gout Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

A Phase 3 Study to Assess the Safety and Efficacy of 12 Months Treatment With Tigulixostat Compared to Allopurinol in Gout Patients With Hyperuricemia
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

A Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment With Tigulixostat in Gout Patients With Hyperuricemia
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

A Phase 3 Study to Assess the Safety and Efficacy of 12 Months Treatment With Tigulixostat Compared to Allopurinol in Gout Patients With Hyperuricemia
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

A Phase 3 Study to Assess the Safety and Efficacy of 6 Months Treatment With Tigulixostat in Gout Patients With Hyperuricemia
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Allopurinol;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients
Conditions:   Gout;   Hyperuricemia;   Gout Flare;   Tophi Interventions:   Drug: Tigulixostat;   Drug: Placebo Sponsor:   LG Chem Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2022 Category: Research Source Type: clinical trials